BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 34061450)

  • 1. Recurrent KCNT2 missense variants affecting p.Arg190 result in a recognizable phenotype.
    Jackson A; Banka S; Stewart H; ; Robinson H; Lovell S; Clayton-Smith J
    Am J Med Genet A; 2021 Oct; 185(10):3083-3091. PubMed ID: 34061450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Additional observation of a de novo pathogenic variant in KCNT2 leading to epileptic encephalopathy with clinical features of frontal lobe epilepsy.
    Inuzuka LM; Macedo-Souza LI; Della-Ripa B; Monteiro FP; Ramos L; Kitajima JP; Garzon E; Kok F
    Brain Dev; 2020 Oct; 42(9):691-695. PubMed ID: 32773162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expanding the phenotypic spectrum consequent upon de novo WDR37 missense variants.
    Hay E; Henderson RH; Mansour S; Deshpande C; Jones R; Nutan S; Mankad K; Young RM; Moosajee M; Research Consortium GE; Arno G
    Clin Genet; 2020 Aug; 98(2):191-197. PubMed ID: 32530092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. KCNT2-Related Disorders: Phenotypes, Functional, and Pharmacological Properties.
    Cioclu MC; Mosca I; Ambrosino P; Puzo D; Bayat A; Wortmann SB; Koch J; Strehlow V; Shirai K; Matsumoto N; Sanders SJ; Michaud V; Legendre M; Riva A; Striano P; Muhle H; Pendziwiat M; Lesca G; Mangano GD; Nardello R; ; Lemke JR; Møller RS; Soldovieri MV; Rubboli G; Taglialatela M
    Ann Neurol; 2023 Aug; 94(2):332-349. PubMed ID: 37062836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lhermitte-Duclos disease with concomitant KCNT2 gene mutation: report of an extremely rare combination.
    Assi J; Chyta M; Mavridis I
    Childs Nerv Syst; 2023 Nov; 39(11):3295-3299. PubMed ID: 37368068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The CHD4-related syndrome: a comprehensive investigation of the clinical spectrum, genotype-phenotype correlations, and molecular basis.
    Weiss K; Lazar HP; Kurolap A; Martinez AF; Paperna T; Cohen L; Smeland MF; Whalen S; Heide S; Keren B; Terhal P; Irving M; Takaku M; Roberts JD; Petrovich RM; Schrier Vergano SA; Kenney A; Hove H; DeChene E; Quinonez SC; Colin E; Ziegler A; Rumple M; Jain M; Monteil D; Roeder ER; Nugent K; van Haeringen A; Gambello M; Santani A; Medne L; Krock B; Skraban CM; Zackai EH; Dubbs HA; Smol T; Ghoumid J; Parker MJ; Wright M; Turnpenny P; Clayton-Smith J; Metcalfe K; Kurumizaka H; Gelb BD; Baris Feldman H; Campeau PM; Muenke M; Wade PA; Lachlan K
    Genet Med; 2020 Feb; 22(2):389-397. PubMed ID: 31388190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primrose syndrome: Characterization of the phenotype in 42 patients.
    Melis D; Carvalho D; Barbaro-Dieber T; Espay AJ; Gambello MJ; Gener B; Gerkes E; Hitzert MM; Hove HB; Jansen S; Jira PE; Lachlan K; Menke LA; Narayanan V; Ortiz D; Overwater E; Posmyk R; Ramsey K; Rossi A; Sandoval RL; Stumpel C; Stuurman KE; Cordeddu V; Turnpenny P; Strisciuglio P; Tartaglia M; Unger S; Waters T; Turnbull C; Hennekam RC
    Clin Genet; 2020 Jun; 97(6):890-901. PubMed ID: 32266967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cantú syndrome versus Zimmermann-Laband syndrome: Report of nine individuals with ABCC9 variants.
    Kortüm F; Niceta M; Magliozzi M; Dumic Kubat K; Robertson SP; Moresco A; Dentici ML; Baban A; Leoni C; Onesimo R; Obregon MG; Digilio MC; Zampino G; Novelli A; Tartaglia M; Kutsche K
    Eur J Med Genet; 2020 Sep; 63(9):103996. PubMed ID: 32622958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A De Novo Mutation in the Sodium-Activated Potassium Channel KCNT2 Alters Ion Selectivity and Causes Epileptic Encephalopathy.
    Gururaj S; Palmer EE; Sheehan GD; Kandula T; Macintosh R; Ying K; Morris P; Tao J; Dias KR; Zhu Y; Dinger ME; Cowley MJ; Kirk EP; Roscioli T; Sachdev R; Duffey ME; Bye A; Bhattacharjee A
    Cell Rep; 2017 Oct; 21(4):926-933. PubMed ID: 29069600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Confirmation and Expansion of the Phenotype Associated with the Recurrent p.Val837Met Variant in TRPM3.
    de Sainte Agathe JM; Van-Gils J; Lasseaux E; Arveiler B; Lacombe D; Pfirrmann C; Raclet V; Gaston L; Plaisant C; Aupy J; Trimouille A
    Eur J Med Genet; 2020 Aug; 63(8):103942. PubMed ID: 32439617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. De Novo and Inherited Pathogenic Variants in KDM3B Cause Intellectual Disability, Short Stature, and Facial Dysmorphism.
    Diets IJ; van der Donk R; Baltrunaite K; Waanders E; Reijnders MRF; Dingemans AJM; Pfundt R; Vulto-van Silfhout AT; Wiel L; Gilissen C; Thevenon J; Perrin L; Afenjar A; Nava C; Keren B; Bartz S; Peri B; Beunders G; Verbeek N; van Gassen K; Thiffault I; Cadieux-Dion M; Huerta-Saenz L; Wagner M; Konstantopoulou V; Vodopiutz J; Griese M; Boel A; Callewaert B; Brunner HG; Kleefstra T; Hoogerbrugge N; de Vries BBA; Hwa V; Dauber A; Hehir-Kwa JY; Kuiper RP; Jongmans MCJ
    Am J Hum Genet; 2019 Apr; 104(4):758-766. PubMed ID: 30929739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. De novo variants in PAK1 lead to intellectual disability with macrocephaly and seizures.
    Horn S; Au M; Basel-Salmon L; Bayrak-Toydemir P; Chapin A; Cohen L; Elting MW; Graham JM; Gonzaga-Jauregui C; Konen O; Holzer M; Lemke J; Miller CE; Rey LK; Wolf NI; Weiss MM; Waisfisz Q; Mirzaa GM; Wieczorek D; Sticht H; Abou Jamra R
    Brain; 2019 Nov; 142(11):3351-3359. PubMed ID: 31504246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Compound heterozygous SZT2 mutations in two siblings with early-onset epilepsy, intellectual disability and macrocephaly.
    Domingues FS; König E; Schwienbacher C; Volpato CB; Picard A; Cantaloni C; Mascalzoni D; Lackner P; Heimbach A; Hoffmann P; Stanzial F; Hicks AA; Parmeggiani L; Benedicenti F; Pellegrin S; Casara G; Pramstaller PP
    Seizure; 2019 Mar; 66():81-85. PubMed ID: 30818181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. De novo variants in SP9 cause a novel form of interneuronopathy characterized by intellectual disability, autism spectrum disorder, and epilepsy with variable expressivity.
    Tessarech M; Friocourt G; Marguet F; Lecointre M; Le Mao M; Díaz RM; Mignot C; Keren B; Héron B; De Bie C; Van Gassen K; Loisel D; Delorme B; Syrbe S; Klabunde-Cherwon A; Jamra RA; Wegler M; Callewaert B; Dheedene A; Zidane-Marinnes M; Guichet A; Bris C; Van Bogaert P; Biquard F; Lenaers G; Marcorelles P; Ferec C; Gonzalez B; Procaccio V; Vitobello A; Bonneau D; Laquerriere A; Khiati S; Colin E
    Genet Med; 2024 May; 26(5):101087. PubMed ID: 38288683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. U2AF2 variant in a patient with developmental delay, dysmorphic features, and epilepsy.
    Kittock CM; Saifeddine M; Straight L; Ward DI
    Am J Med Genet A; 2023 Jul; 191(7):1968-1972. PubMed ID: 37092751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathogenic variants in KCNQ2 cause intellectual deficiency without epilepsy: Broadening the phenotypic spectrum of a potassium channelopathy.
    Mary L; Nourisson E; Feger C; Laugel V; Chaigne D; Keren B; Afenjar A; Billette T; Trost D; Cieuta-Walti C; Gerard B; Piton A; Schaefer E
    Am J Med Genet A; 2021 Jun; 185(6):1803-1815. PubMed ID: 33754465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. De Novo Missense Variants in TRAF7 Cause Developmental Delay, Congenital Anomalies, and Dysmorphic Features.
    Tokita MJ; Chen CA; Chitayat D; Macnamara E; Rosenfeld JA; Hanchard N; Lewis AM; Brown CW; Marom R; Shao Y; Novacic D; Wolfe L; Wahl C; Tifft CJ; Toro C; Bernstein JA; Hale CL; Silver J; Hudgins L; Ananth A; Hanson-Kahn A; Shuster S; ; Magoulas PL; Patel VN; Zhu W; Chen SM; Jiang Y; Liu P; Eng CM; Batkovskyte D; di Ronza A; Sardiello M; Lee BH; Schaaf CP; Yang Y; Wang X
    Am J Hum Genet; 2018 Jul; 103(1):154-162. PubMed ID: 29961569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Homozygous missense STRADA mutation in a patient with polyhydramnios, megalencephaly and symptomatic epilepsy syndrome.
    Aerden M; Vallaeys L; Holvoet M; De Waele L; Van Den Bogaert K; Devriendt K
    Clin Dysmorphol; 2021 Jul; 30(3):121-124. PubMed ID: 33605605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. De novo missense variants in PPP2R5D are associated with intellectual disability, macrocephaly, hypotonia, and autism.
    Shang L; Henderson LB; Cho MT; Petrey DS; Fong CT; Haude KM; Shur N; Lundberg J; Hauser N; Carmichael J; Innis J; Schuette J; Wu YW; Asaikar S; Pearson M; Folk L; Retterer K; Monaghan KG; Chung WK
    Neurogenetics; 2016 Jan; 17(1):43-9. PubMed ID: 26576547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PAK1 c.1409 T > a (p. Leu470Gln) de novo variant affects the protein kinase domain, leading to epilepsy, macrocephaly, spastic quadriplegia, and hydrocephalus: Case report and review of the literature.
    Corriveau ML; Amaya SI; Koebel MC; Lerma VC; Michener SL; Turner A; Schultz RJ; Seto ES; Diaz-Medina GE; Craigen WJ; Swann JW; Xue M; Chao HT
    Am J Med Genet A; 2023 Jun; 191(6):1619-1625. PubMed ID: 36905087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.